Annual Gross Profit
$1.15 M
+$144.90 K+14.48%
31 December 2023
Summary:
Predictive Oncology annual gross profit is currently $1.15 million, with the most recent change of +$144.90 thousand (+14.48%) on 31 December 2023. During the last 3 years, it has risen by +$340.20 thousand (+42.26%). POAI annual gross profit is now at all-time high.POAI Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$148.80 K
+$23.00 K+18.28%
30 September 2024
Summary:
Predictive Oncology quarterly gross profit is currently $148.80 thousand, with the most recent change of +$23.00 thousand (+18.28%) on 30 September 2024. Over the past year, it has dropped by -$430.00 thousand (-74.29%). POAI quarterly gross profit is now -74.29% below its all-time high of $578.80 thousand, reached on 30 September 2023.POAI Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$711.50 K
-$430.00 K-37.67%
30 September 2024
Summary:
Predictive Oncology TTM gross profit is currently $711.50 thousand, with the most recent change of -$430.00 thousand (-37.67%) on 30 September 2024. Over the past year, it has dropped by -$527.40 thousand (-42.57%). POAI TTM gross profit is now -47.14% below its all-time high of $1.35 million, reached on 31 March 2024.POAI TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.5% | -74.3% | -42.6% |
| 3 y3 years | +42.3% | -26.9% | -10.3% |
| 5 y5 years | +15.0% | -52.7% | -18.1% |
POAI Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.3% | -74.3% | +24.2% | -47.1% | at low |
| 5 y | 5 years | at high | +42.3% | -74.3% | +52.6% | -47.1% | at low |
| alltime | all time | at high | -74.3% | +913.1% | -47.1% |
Predictive Oncology Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $148.80 K(+18.3%) | $711.50 K(-37.7%) |
| June 2024 | - | $125.80 K(-45.8%) | $1.14 M(-15.2%) |
| Mar 2024 | - | $232.20 K(+13.4%) | $1.35 M(+9.1%) |
| Dec 2023 | $1.15 M(+14.5%) | $204.70 K(-64.6%) | $1.23 M(-0.4%) |
| Sept 2023 | - | $578.80 K(+75.2%) | $1.24 M(+22.9%) |
| June 2023 | - | $330.30 K(+175.7%) | $1.01 M(+10.1%) |
| Mar 2023 | - | $119.80 K(-43.0%) | $915.00 K(-8.5%) |
| Dec 2022 | $1.00 M(+7.1%) | $210.00 K(-39.6%) | $1.00 M(-11.5%) |
| Sept 2022 | - | $347.70 K(+46.4%) | $1.13 M(+14.6%) |
| June 2022 | - | $237.50 K(+15.8%) | $986.40 K(+3.2%) |
| Mar 2022 | - | $205.10 K(-39.7%) | $956.20 K(+2.4%) |
| Dec 2021 | $933.70 K(+16.0%) | $340.30 K(+67.2%) | $933.70 K(+17.7%) |
| Sept 2021 | - | $203.50 K(-1.8%) | $793.10 K(-11.4%) |
| June 2021 | - | $207.30 K(+13.5%) | $895.20 K(+14.0%) |
| Mar 2021 | - | $182.60 K(-8.6%) | $785.40 K(-2.4%) |
| Dec 2020 | $805.10 K(-8.5%) | $199.70 K(-34.7%) | $805.10 K(-2.0%) |
| Sept 2020 | - | $305.60 K(+213.4%) | $821.30 K(-1.1%) |
| June 2020 | - | $97.50 K(-51.8%) | $830.30 K(-7.8%) |
| Mar 2020 | - | $202.30 K(-6.3%) | $900.60 K(+2.4%) |
| Dec 2019 | $879.80 K(-11.7%) | $215.90 K(-31.4%) | $879.80 K(+1.2%) |
| Sept 2019 | - | $314.60 K(+87.5%) | $869.00 K(+8.4%) |
| June 2019 | - | $167.80 K(-7.5%) | $801.30 K(-9.3%) |
| Mar 2019 | - | $181.50 K(-11.5%) | $883.10 K(-11.3%) |
| Dec 2018 | $995.90 K(+96.5%) | $205.10 K(-16.9%) | $995.90 K(+4.7%) |
| Sept 2018 | - | $246.90 K(-1.1%) | $950.80 K(+14.9%) |
| June 2018 | - | $249.60 K(-15.2%) | $827.70 K(+24.9%) |
| Mar 2018 | - | $294.30 K(+83.9%) | $662.90 K(+30.8%) |
| Dec 2017 | $506.80 K(+84.4%) | $160.00 K(+29.2%) | $506.80 K(+11.7%) |
| Sept 2017 | - | $123.80 K(+46.0%) | $453.90 K(+3.6%) |
| June 2017 | - | $84.80 K(-38.6%) | $438.20 K(+9.0%) |
| Mar 2017 | - | $138.20 K(+29.0%) | $402.10 K(+46.3%) |
| Dec 2016 | $274.90 K | $107.10 K(-0.9%) | $274.90 K(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $108.10 K(+122.0%) | $246.40 K(+20.6%) |
| June 2016 | - | $48.70 K(+342.7%) | $204.30 K(-33.2%) |
| Mar 2016 | - | $11.00 K(-86.0%) | $306.00 K(-12.6%) |
| Dec 2015 | $350.40 K(-38.1%) | $78.60 K(+19.1%) | $350.30 K(+10.7%) |
| Sept 2015 | - | $66.00 K(-56.1%) | $316.30 K(-38.3%) |
| June 2015 | - | $150.40 K(+172.0%) | $512.80 K(-11.9%) |
| Mar 2015 | - | $55.30 K(+24.0%) | $582.30 K(+2.9%) |
| Dec 2014 | $566.20 K(+103.4%) | $44.60 K(-83.0%) | $566.10 K(+3.2%) |
| Sept 2014 | - | $262.50 K(+19.4%) | $548.60 K(+49.2%) |
| June 2014 | - | $219.90 K(+462.4%) | $367.80 K(+58.9%) |
| Mar 2014 | - | $39.10 K(+44.3%) | $231.40 K(-16.9%) |
| Dec 2013 | $278.40 K(+362.5%) | $27.10 K(-66.8%) | $278.40 K(-6.5%) |
| Sept 2013 | - | $81.70 K(-2.2%) | $297.80 K(+50.6%) |
| June 2013 | - | $83.50 K(-3.0%) | $197.80 K(+43.9%) |
| Mar 2013 | - | $86.10 K(+85.2%) | $137.50 K(+128.4%) |
| Dec 2012 | $60.20 K(+48.3%) | $46.50 K(-354.1%) | $60.20 K(+35.0%) |
| Sept 2012 | - | -$18.30 K(-178.9%) | $44.60 K(-38.1%) |
| June 2012 | - | $23.20 K(+163.6%) | $72.00 K(+45.7%) |
| Mar 2012 | - | $8800.00(-71.5%) | $49.40 K(+21.7%) |
| Dec 2011 | $40.60 K(>+9900.0%) | $30.90 K(+239.6%) | $40.60 K(+318.6%) |
| Sept 2011 | - | $9100.00(+1416.7%) | $9700.00(+1516.7%) |
| June 2011 | - | $600.00(>+9900.0%) | $600.00(>+9900.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2010 | $100.00(-98.9%) | $0.00(0.0%) | $100.00(-80.0%) |
| Sept 2010 | - | $0.00(0.0%) | $500.00(0.0%) |
| June 2010 | - | $0.00(-100.0%) | $500.00(-94.3%) |
| Mar 2010 | - | $100.00(-75.0%) | $8800.00(+1.1%) |
| Dec 2009 | $8700.00(>+9900.0%) | $400.00(>+9900.0%) | $8700.00(+4.8%) |
| Sept 2009 | - | $0.00(-100.0%) | $8300.00(0.0%) |
| June 2009 | - | $8300.00(>+9900.0%) | $8300.00(>+9900.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2008 | - | $0.00 | $0.00 |
FAQ
- What is Predictive Oncology annual gross profit?
- What is the all time high annual gross profit for Predictive Oncology?
- What is Predictive Oncology annual gross profit year-on-year change?
- What is Predictive Oncology quarterly gross profit?
- What is the all time high quarterly gross profit for Predictive Oncology?
- What is Predictive Oncology quarterly gross profit year-on-year change?
- What is Predictive Oncology TTM gross profit?
- What is the all time high TTM gross profit for Predictive Oncology?
- What is Predictive Oncology TTM gross profit year-on-year change?
What is Predictive Oncology annual gross profit?
The current annual gross profit of POAI is $1.15 M
What is the all time high annual gross profit for Predictive Oncology?
Predictive Oncology all-time high annual gross profit is $1.15 M
What is Predictive Oncology annual gross profit year-on-year change?
Over the past year, POAI annual gross profit has changed by +$144.90 K (+14.48%)
What is Predictive Oncology quarterly gross profit?
The current quarterly gross profit of POAI is $148.80 K
What is the all time high quarterly gross profit for Predictive Oncology?
Predictive Oncology all-time high quarterly gross profit is $578.80 K
What is Predictive Oncology quarterly gross profit year-on-year change?
Over the past year, POAI quarterly gross profit has changed by -$430.00 K (-74.29%)
What is Predictive Oncology TTM gross profit?
The current TTM gross profit of POAI is $711.50 K
What is the all time high TTM gross profit for Predictive Oncology?
Predictive Oncology all-time high TTM gross profit is $1.35 M
What is Predictive Oncology TTM gross profit year-on-year change?
Over the past year, POAI TTM gross profit has changed by -$527.40 K (-42.57%)